Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and

5-Hydroxyindole acetic acid Dopamine transporter Homovanillic acid MIBG Parkinson's disease Serotonin

Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 15 05 2024
revised: 30 08 2024
accepted: 31 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: aheadofprint

Résumé

Cerebrospinal fluid (CSF) homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), dopamine and serotonin metabolites, are decreased in Parkinson's disease (PD). Although some reported associations between HVA and striatal dopamine transporter (DAT) or 5-HIAA and cardiac

Identifiants

DOI: 10.1016/j.parkreldis.2024.107129 PMID: 39241507
pubmed: 39241507
pii: S1353-8020(24)01141-6
doi: 10.1016/j.parkreldis.2024.107129
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107129

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Masanori Kurihara reports financial support was provided by Japan Society for the Promotion of Science. Masanori Kurihara reports financial support was provided by Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ryosuke Shimasaki (R)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Masanori Kurihara (M)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan; Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan. Electronic address: mkurihara-tky@umin.ac.jp.

Keiko Hatano (K)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Ryoji Goto (R)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Kenichiro Taira (K)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Ryoko Ihara (R)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Mana Higashihara (M)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Yasushi Nishina (Y)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Masashi Kameyama (M)

Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan; Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Atsushi Iwata (A)

Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan; Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan.

Classifications MeSH